FDA information regarding Biosimilars

Posted in Latest News on August 26, 2013.

The FDA has created a pathway for the approval of biosimilar products, but has not yet approved a biological product as biosimilar or interchangeable. There is no date-certain for when these products will be approved—some estimates are three to five years.
The Board of Pharmacy has established a link on its website to the FDA pathway for approval of biosimilar biological products.



More Latest News

International Export Pharmacy Permit
June 13, 2019

Click here for information on the new international export pharmacy permit allowing safe importation of FDA-approved prescription drugs, pending federal approval. Continue reading


Board Chairs/Vice Chairs Annual Long-range Planning Meeting
June 12, 2019

The Annual Long Range Planning meeting has been scheduled for Friday, October 18, 2019. Please click here for more information. Continue reading